Drug Discovery

Improving Drug Discovery by Exploring the Human Proteome

Advancements in mass spectrometry are helping to gain a better understanding of previously inaccessible areas of the human proteome

by Hokkaido University

Comprehensive and efficient method for screening drug candidates could advance the fight against drug-resistant bacteria

Advanced study of the drug tirzepatide finds it could be an effective treatment for obstructive sleep apnea

The latest addition to the NovoCyte family, the NovoCyte Opteon, celebrates a decade of flow cytometry excellence

The new platform helped UC San Diego scientists synthesize 32 potential multi-target cancer drugs

Researchers leverage a new AI model, SyntheMol, which creates recipes for chemists to synthesize drugs

by McMaster University

Novel AI model, SyntheMol, generates billions of inexpensive antibiotic molecules targeting drug-resistant bacteria

Research on protein evolution reveals new starting points for the rapid and targeted development of future drugs

The SemaCyte Multiplexing Platform is an expansion of an existing platform that enables new features for drug discovery

by Sartorius,Lab Manager

Techniques that are streamlining the drug discovery pipeline, enhancing efficiency and accuracy

Innovative platform helps design molecules that can target helicases involved in numerous diseases